Tetrahydrofuran

Tetrahydrofuran

SCHEMBL6008619

C1CCOC1.COc1nn2c(-c3c(C)cc(N(C)C)nc3C)cccc2c1N(C)CC1CC1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5540102 0.99 CRHR1 (0.56) CRHR1
SCHEMBL1942006 0.90 CRHR1 (0.71) CRHR1
SCHEMBL5540096 0.88 CRHR1 (0.59) CRHR1
Tetrahydrofuran SCHEMBL5544247 0.87 CRHR1 (0.56) CRHR1
SCHEMBL5546393 0.86 CRHR1 (0.55) CRHR1
SCHEMBL1943043 0.86 CRHR1 (0.66) CRHR1
Tetrahydrofuran SCHEMBL5541620 0.86 CRHR1 (0.52) CRHR1
SCHEMBL5536257 0.85 CRHR1 (0.51) CRHR1
SCHEMBL1940358 0.79 CRHR1 (0.70) CRHR1
SCHEMBL5546390 0.77 CRHR1 (0.65) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091215-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI CO., LTD. (JP) 2006-08-15 US disclosed
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same XDH, NR3C1, NR5A1 CRHR1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.